Eflornithine with lomustine for treating anaplastic astrocytoma after radiotherapy and adjuvant temozolomide TS ID 10046Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Vorasidenib for treating astrocytoma or oligodendroglioma with IDH1 or IDH2 mutations after surgery in people 12 years and over TS ID 11974Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC